Is plasma homocysteine a modifiable risk factor for stroke? (Q36577229)

15 August 2017

1 reference

title

Is plasma homocysteine a modifiable risk factor for stroke? (English)

1 reference

15 August 2017

0 references

Graeme J Hankey

1

0 references

publication date

1 January 2006

1 reference

Nature Clinical Practice Neurology

15 August 2017

1 reference

15 August 2017

2

1 reference

15 August 2017

1

1 reference

15 August 2017

26-33

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpneuro0093

15 August 2017

0 references

cites work

Homocysteine and its disulfide derivatives: a suggested consensus terminology

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

Homocysteine and stroke: evidence on a causal link from mendelian randomisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

Power Shortage: clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

Vitamin B12, homocysteine and carotid plaque in the era of folic acid fortification of enriched cereal grain products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

21 January 2018

Homocysteine and stroke

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

Folate, homocysteine, endothelial function and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Facts and recommendations about total homocysteine determinations: an expert opinion

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Drugs affecting homocysteine metabolism: impact on cardiovascular risk

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Is there really a power shortage in clinical trials testing the "homocysteine hypothesis?".

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized subs

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Hyperhomocysteinemia evoked by folate depletion: effects on coronary and carotid arterial function

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Hyperhomocysteinemia: a million ways to lose control

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Dietary intake of folate and risk of stroke in US men and women: NHANES I Epidemiologic Follow-up Study. National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Folate, vitamin B6, and B12 intakes in relation to risk of stroke among men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 μmol/L

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Decreased rate of coronary restenosis after lowering of plasma homocysteine levels

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Folate therapy and in-stent restenosis after coronary stenting

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

An alternative view of homocysteine

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Homocysteine and stroke

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Folic acid-based multivitamin therapy to prevent stroke: the jury is still out.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

The effect of folic acid fortification on plasma folate and total homocysteine concentrations

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Sustained homocysteine-lowering effect over time of folic acid-based multivitamin therapy in stroke patients despite increasing folate status in the population

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Is folic acid the ultimate functional food component for disease prevention?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0093

7 January 2021

Identifiers

DOI

10.1038/NCPNEURO0093

1 reference

PubMed ID

16932518

Dimensions Publication ID

15 August 2017

0 references

1 reference

PubMed ID

16932518